Browse by Title

Type here to filter the list

L
LAP&P course: An interactive translational pharmacometric case study for an antibody exhibiting TMDD, LAP&P Consultants BV
Favorite

Tamara van Steeg – LAP&P Consultants BV ### 2343516###Speaker###Principal Consultant Pharmacometrician, Director Research###LAP&P Consultants BV###
Speaker: Tamara van Steeg – LAP&P Consultants BV
### @@@ Sven Hoefman ### 2343517###Speaker#########
Speaker: Sven Hoefman
### @@@ Richard Hooijmaijers ### 2343518###Speaker#########
Speaker: Richard Hooijmaijers
###
LAP&P course; An interactive translational pharmacometric case study for an antibody exhibiting TMDD, LAP&P Consultants BV
Favorite

Tamara van Steeg – LAP&P Consultants BV ### 2343516###Speaker###Principal Consultant Pharmacometrician, Director Research###LAP&P Consultants BV###
Speaker: Tamara van Steeg – LAP&P Consultants BV
### @@@ Sven Hoefman ### 2343517###Speaker#########
Speaker: Sven Hoefman
### @@@ Richard Hooijmaijers ### 2343518###Speaker#########
Speaker: Richard Hooijmaijers
###
Large language model and active learning guided pharmacology therapy knowledge gap discovery in maternal and pediatric patients
Favorite

Lang Li, PhD – Department of Biomedical Informatics, College of Medicine, The Ohio State University ### 2407905###Speaker###Professor and Chair###Department of Biomedical Informatics, College of Medicine, The Ohio State University###
Speaker: Lang Li, PhD – Department of Biomedical Informatics, College of Medicine, The Ohio State University
###
Large Molecule Minimal PBPK Models and FcRn Interactions
Favorite

Dongfen Yuan, PhD – Janssen Research & Development ### 2408458###Speaker###Associate Director###Janssen Research & Development###
Speaker: Dongfen Yuan, PhD – Janssen Research & Development
###
Leveraging effective communication skills to deliver complex pharmacometrics results to non-pharmacometricians
Favorite

Paolo Vicini, PhD, MBA (he/him/his) – Confo Therapeutics ### 2474036###Speaker###Chief Development Officer###Confo Therapeutics###
Speaker: Paolo Vicini, PhD, MBA (he/him/his) – Confo Therapeutics
### he/him/his
Leveraging quantitative models to design and develop the next generation of multi-specific T-Cell engager molecules
Favorite

Isabel M. Figueroa, PhD – Gilead ### 2360733###Chair###Director###Gilead###
Chair: Isabel M. Figueroa, PhD – Gilead
### @@@ Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech ### 2360734###Chair###Distinguished Scientist###Genentech###
Chair: Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech
### @@@ Jin Niu, PhD (she/her/hers) – J&J ### 2360735###Speaker###Senior Scientist###J&J###
Speaker: Jin Niu, PhD (she/her/hers) – J&J
### she/her/hers @@@ Brian Schmidt ### 2407942###Speaker#########
Speaker: Brian Schmidt
### @@@ Alexander Kulesza, PhD (he/him/his) – Systems Pharmacology Lead ### 2343520###Speaker###Principal Scientist###Systems Pharmacology Lead###
Speaker: Alexander Kulesza, PhD (he/him/his) – Systems Pharmacology Lead
### he/him/his
Lewis B. Sheiner Award Lecture
Favorite

Donald E. Mager, PharmD, PhD (he/him/his) – University at Buffalo, SUNY ### 2343508###Speaker###Professor and Chair###University at Buffalo, SUNY###
Speaker: Donald E. Mager, PharmD, PhD (he/him/his) – University at Buffalo, SUNY
### he/him/his